Support for the development of HTA-compliant health economics strategies for medical devices.
An era where clinical effectiveness alone is not enough to be chosen. Gradual support for HTA compliance and proof of value.
Against the backdrop of rising medical costs, health technology assessment (HTA) is being emphasized in various countries as a key factor in decisions regarding insurance reimbursement and pricing. In Japan, a cost-effectiveness evaluation system was fully introduced in 2019, and in Europe, the application of the EU HTA regulation will begin in 2025. This service supports the transition of HTA response from "pre-application work" to "value design from the development stage." We provide step-by-step assistance in understanding HTA requirements, conducting evidence gap analysis, formulating evidence plans, building health economic models, and developing pricing and market access strategies. We offer HTA requirement diagnostics (free of charge). Please feel free to contact us if you are interested.
Inquire About This Product
basic information
【Service Overview】 Support for HTA compliance and health economics strategy formulation for medical devices (diagnosis and consulting) Provided by: Accenture Supply Chain & Engineering (SC&E) 【Target Audience】 Management of medical device manufacturers, market access, regulatory affairs, development, business planning 【Structure (4 Layers)】 Data infrastructure / Evidence planning / Health economic analysis / Pricing and market access strategy 【Approach】 STEP 1 (0-6 months) Understanding HTA requirements and gap analysis STEP 2 (6-18 months) Building evidence of value and developing analysis models STEP 3 (18 months and beyond) International expansion and ongoing proof of value 【Entry Point】 HTA requirement diagnosis (free of charge)
Price range
Delivery Time
Applications/Examples of results
【Main Uses】 - Organize HTA requirements for each target country and compare them with the current evidence of our products. - From the early stages of development, establish comparative controls, evaluation metrics, and data to be collected, accumulating evidence of value in parallel with clinical trials. - Build healthcare economic models such as cost-effectiveness analysis and budget impact analysis. - Utilize pre-consultations with evaluation agencies to gather evidence that can withstand scrutiny during applications. - Develop a common foundation of value tailored for each country, and continuously verify value with real-world clinical data post-launch, reflecting this in pricing strategies. 【Examples of Achievements】 (If there are case studies, please add them here) We are currently accepting requests starting with the "HTA Requirements Diagnosis (free of charge)."
catalog（1）
Download All Catalogs
Company information
Accenture transforms change into power, providing 360-degree value to customers, employees, shareholders, partner companies, and society. We support Bristol Myers Squibb by leveraging generative AI and automation to accelerate clinical trials and streamline drug development. We consolidate our full capabilities as a reinvention service to solve the most challenging problems. We guide enterprise transformation to be executed on a larger scale and with greater impact.
